Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-05-04T14:56:49.535Z Has data issue: false hasContentIssue false

Case series: propranolol liquid in the treatment of tachyarrhythmias in neonates and infants: potential for errors

Published online by Cambridge University Press:  29 June 2022

Catherine E. Renwick*
Affiliation:
Children’s Cardio-respiratory and Intensive Care Directorate, Royal Brompton Hospital (Guy’s and St Thomas’ NHS Foundation Trust), London, United Kingdom
Sukeshi Makhecha
Affiliation:
Children’s Cardio-respiratory and Intensive Care Directorate, Royal Brompton Hospital (Guy’s and St Thomas’ NHS Foundation Trust), London, United Kingdom
Jan Till
Affiliation:
Children’s Cardio-respiratory and Intensive Care Directorate, Royal Brompton Hospital (Guy’s and St Thomas’ NHS Foundation Trust), London, United Kingdom
*
Address for correspondence: Catherine Renwick, Consultant Nurse, Royal Brompton Hospital, Sydney Street, Chelsea, London, SW3 6NP, United Kingdom. Tel: 0207 352 8121 Ext 88550. E-mail: c.renwick@rbht.nhs.uk

Abstract

Oral propranolol therapy is commonly used for the prevention of tachyarrhythmias in infancy and childhood. Propranolol is commercially produced in four concentrations allowing varying volumes to be administered. However, quite often an alternative strength of propranolol liquid is issued without clear change in instructions or warning. This may lead to parents inadvertently administering the wrong dose.

Type
Brief Report
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brugada, J, Blom, N, Sarquella-Brugada, G. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace 2013; 15: 13371382.CrossRefGoogle Scholar
Paediatric Formulary Committee. BNF for Children (online) London: BMJ Group, Pharmaceutical Press, and RCPCH Publications https://bnfc.nice.org.uk/drug/propranolol-hydrochloride.html [Accessed on [14/04/2022]]Google Scholar
Sutcliffe, K, Stokes, G, O’Mara, A. Paediatric Medication Error: A Systematic Review of the Extent and Nature of the Problem in the UK and International Interventions to Address It. EPPI-Centre, Social Science Research Unit, Institute of Education, University of London, London, 2014. ISBN: 978-1-907345-73-9,Google Scholar
Department of Health. Managing Medicines in Schools and Early Years Settings. DFES Publications, 2005. ,Google Scholar
Henderson, R. Prescribing for Children. Patient. EMIS group PLC EMIS Group plc <http://patient.info/doctor/prescribing-for-children> [accessed on [14/04/2022]]+[accessed+on+[14/04/2022]]>Google Scholar
Paediatric Formulary Committee. BNF for Children (online) London: BMJ Group, Pharmaceutical Press, and RCPCH Publications https://bnfc.nice.org.uk/medicinal-forms/propranolol-hydrochloride.html [Accessed on [24/04/2022]]Google Scholar
National Patient Safety Agency. The Fourth Report from the Patient Safety Observatory: Safety in Doses: Medication Safety Incidents in the NHS. National Patient Safety Agency, London, 2007.Google Scholar
Ghaleb, MA, Barber, N, Franklin, BD, Wong, ICK. The incidence and nature of prescribing and medication administration errors in paediatric inpatients. Arch Dis Child 2010; 95: 113118.CrossRefGoogle ScholarPubMed
Neonatal and Paediatric Pharmacist Group (NPPG). Position statement 2020-01: Choosing an Oral Liquid Medication for Children. <http://nppg.org.uk/wp-content/uploads/2020/12/Position-Statement-Liquid-Choice-V1-November-2020.pdf> [accessed on [13/05/2022]]+[accessed+on+[13/05/2022]]>Google Scholar